Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · IEX Real-Time Price · USD

0.584

-0.043 (-6.87%)

At close: Apr 18, 2024, 4:00 PM

0.594

+0.009 (1.59%)

After-hours: Apr 18, 2024, 7:44 PM EDT

Seres Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	136.15	171.22	188	116.05	65.13	85.93	36.2	55.94	75.47	114.32	Upgrade
Short-Term Investments	0	18.31	110.7	137.57	29.69	0	113.9	138.7	131.15	0	Upgrade
Cash & Cash Equivalents	136.15	189.53	298.71	253.62	94.82	85.93	150.1	194.64	206.62	114.32	Upgrade
Cash Growth	-28.16%	-36.55%	17.78%	167.48%	10.34%	-42.75%	-22.89%	-5.80%	80.73%	6660.73%	Upgrade
Receivables	8.67	0	0	9.39	1.79	0	0	0	0	0	Upgrade
Inventory	29.65	0	0	0	0	0	0	0	0	0	Upgrade
Other Current Assets	0.94	5.24	4.92	5.77	3.59	6.73	4.98	3.73	0.99	-0.08	Upgrade
Total Current Assets	175.41	194.76	303.63	268.78	100.19	92.67	155.08	198.37	207.61	114.24	Upgrade
Property, Plant & Equipment	132.25	133.97	36.15	22.94	30.85	26.29	32.93	36.13	7.75	1.26	Upgrade
Long-Term Investments	1.4	1.4	1.9	51.23	1.4	1.4	1.4	36.75	0	0	Upgrade
Other Long-Term Assets	49.54	18.65	13.19	0	0	0.11	0.11	1.4	1.54	1.84	Upgrade
Total Long-Term Assets	183.19	154.02	51.23	74.16	32.25	27.81	34.44	74.28	9.29	3.1	Upgrade
Total Assets	358.6	348.78	354.86	342.94	132.44	120.47	189.52	272.65	216.9	117.35	Upgrade
Accounts Payable	3.64	17.44	13.74	4.02	4.86	6.42	7.03	7.59	5.4	2.17	Upgrade
Deferred Revenue	103.09	96.69	103.82	108.17	119.74	137.26	96.93	108.81	0	0	Upgrade
Current Debt	6.68	4.06	6.61	5.57	4.46	0	0	0	0	1.2	Upgrade
Other Current Liabilities	-14.75	-32.59	-41.9	-71.35	-83.06	-101.63	-72.33	-85.94	5.52	1.74	Upgrade
Total Current Liabilities	98.66	85.6	82.26	46.42	45.99	42.04	31.63	30.46	10.92	5.1	Upgrade
Long-Term Debt	207.26	158.53	42.6	35.2	40.32	0	0	0	0	1.3	Upgrade
Other Long-Term Liabilities	97.54	93.87	98.49	86.58	94.45	126.48	97.2	109.56	0.59	1.58	Upgrade
Total Long-Term Liabilities	304.8	252.41	141.09	121.78	134.77	126.48	97.2	109.56	0.59	2.89	Upgrade
Total Liabilities	403.46	338	223.35	168.19	180.76	168.52	128.82	140.02	11.51	7.99	Upgrade
Total Debt	213.94	162.59	49.21	40.77	44.78	0	0	0	0	2.5	Upgrade
Debt Growth	31.58%	230.39%	20.71%	-8.96%	-	-	-	-	-	198.81%	Upgrade
Retained Earnings	-978.24	-864.51	-614.35	-548.78	-459.65	-389.37	-263.57	-174.19	-82.61	-27.83	Upgrade
Comprehensive Income	0	-0.01	-0.06	-0.05	0	0	-0.15	-0.15	0.03	0	Upgrade
Shareholders' Equity	-44.86	10.78	131.51	174.75	-48.32	-48.05	60.7	132.63	205.39	-26.72	Upgrade
Net Cash / Debt	-77.79	26.94	249.5	212.85	50.04	85.93	150.1	194.64	206.62	111.82	Upgrade
Net Cash / Debt Growth	-	-89.20%	17.22%	325.39%	-41.77%	-42.75%	-22.89%	-5.80%	84.78%	13009.03%	Upgrade
Net Cash Per Share	-0.61	0.25	2.72	2.67	0.88	2.11	3.71	4.88	8.78	16.57	Upgrade
Working Capital	76.75	109.17	221.37	222.36	54.2	50.62	123.45	167.91	196.69	109.14	Upgrade
Book Value Per Share	-0.35	0.10	1.43	2.19	-0.85	-1.18	1.50	3.33	8.73	-3.96	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).